Publications by authors named "Ada Dona"

Claim this Profile
P
Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects.
Ada Alice Dona, Theophilus Tandoh, Lokesh Nigam, Mahmoud Singer, Enrico Caserta

J Hematol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD38-directed, single-chain T-cell engager targets leukemia stem cells through IFN-γ-induced CD38 expression.
Mariam Murtadha, Miso Park, Yinghui Zhu, Enrico Caserta, Ottavio Napolitano, Ada Alice Dona

Blood· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemia.
Mariam Murtadha, Miso Park, Yinghui Zhu, Enrico Caserta, Ada Alice Dona

bioRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leflunomide Confers Rapid Recovery from COVID-19 and is Coupled with Temporal Immunologic Changes.
Ada Alice Dona, James F Sanchez, Joycelynne M Palmer, Timothy W Synold, Flavia Chiuppesi

J Immunol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic herpes simplex virus infects myeloma cells and .
Jayeeta Ghose, Ada Dona, Mariam Murtadha, Emine Gulsen Gunes, Enrico Caserta

Mol Ther Oncolytics· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting.
Domenico Viola, Ada Dona, Enrico Caserta, Estelle Troadec, Francesca Besi, Tinisha McDonald

Leukemia· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages.
Jihane Khalife, Jayeeta Ghose, Marianna Martella, Domenico Viola, Alberto Rocci, Ada Dona

JCI Insight· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer.
Michele Pellegrino, Pietro Rizza, Ada Donà, Alessandra Nigro, Elena Ricci

Cancers (Basel)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach.
Carlo Baggio, Luca Gambini, Parima Udompholkul, Ahmed F Salem, Alexander Aronson, Ada Dona

J Med Chem· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligand activated progesterone receptor B drives autophagy-senescence transition through a Beclin-1/Bcl-2 dependent mechanism in human breast cancer cells.
Francesca De Amicis, Carmela Guido, Marta Santoro, Francesca Giordano, Ada Donà, Donatella Tramontano

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor.
Ivan Casaburi, Maria Grazia Cesario, Ada Donà, Pietro Rizza, Saveria Aquila

Oncotarget· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bergapten induces metabolic reprogramming in breast cancer cells.
Marta Santoro, Carmela Guido, Francesca De Amicis, Diego Sisci, Erika Cione

Oncol Rep· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis